Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials. (2026). SKIN The Journal of Cutaneous Medicine, 10(3), s772. https://doi.org/10.25251/pkdcct35